4Gris JC, Ripart-Neveu S, Maugard C, et al. Prospective evaluation of the prevalence of haemostasis alnormalities in unexplained primary early recurrent miscarriages.Thromb Haemost, 1997,6:1096-1103.
5Ogasawara M, Aoki K, Okada S, et al. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril, 2000, 73 (2) :300.
6Frosst P,Blom HJ, Milos R,et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet, 1995,10:111.
7Van der put NMJ,Gabreels F,Stevens EMB,et al. A second common mutation in the methylenetetrahydrofolate reductase gene:An additional risk factor for neural-tube defects? Am J Hum Genet, 1998,62:1044.
8Lissak A, Sharon A, Fruchters, et al. Polymorphism for mutation of cytocine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss. Obstet Gynecol, 1999 ,181:126.
9Holmes ZR,Regan L,Chilcott I,et al.The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. Br J Haematology, 1999,105:98.
10Weinsberg I, Tran P, Christensen B, et al. A second genetic polymorphism methylenetetrahydrofolate reductase(MTHFR)associated with decreased enzyme activity. Mole Gene & Metabolism, 1998,64:169.
8Yang CJ,Stone P,Stewart AW. The epidemiology of re-current miscarriage:a descriptive study of 1 214prepregnant women with recurrent miscarriage[J].Aust NZ J Obstet Gynaecol,2006,46 (4): 316-322.
9Finan RR,Tamim H.Ameen G,et al.Prevalence of factorV G1691A (factor V-Leiden) and prothrombin G20210Agene mutations in a recurrent miscarriage population[Jh Am J Hematol, 2002, 71 (4) :300-305.
